NCT02405832View on ClinicalTrials.gov

Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome

NACompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

March 10, 2015

Primary Completion Date

April 4, 2015

Study Completion Date

April 4, 2015

Conditions
Sore ThroatPost-Operative Sore Throat
Interventions
DIETARY_SUPPLEMENT

Zinc

Oral administration of a 40 mg elemental zinc (in the form of zinc sulfate) lozenge, with sweetener and citrus flavor

DIETARY_SUPPLEMENT

Placebo

Placebo lozenge, with sweetener and citrus flavor, administered orally

Trial Locations (1)

05401

University of Vermont Medical Center, Burlington

All Listed Sponsors
lead

University of Vermont

OTHER

NCT02405832 - Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome | Biotech Hunter | Biotech Hunter